NASDAQ:RLYP - Relypsa Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$31.99 0.00 (0.00 %)
(As of 07/22/2018 04:00 PM ET)
Previous Close$31.99
Today's Range$31.99 - $31.99
52-Week Range$10.26 - $32.12
Average Volume2.93 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Relypsa logoRelypsa, Inc. is a United States-based biopharmaceutical company. The Company focuses on the discovery, development and commercialization of polymer-based medicines. The Company's technology platform includes a high-throughput chemistry process, enabling the Company to explore various potential polymer medicines for each disease it seeks to address. Its polymers are non-absorbed, meaning they act within the gastrointestinal tract and do not get absorbed into the bloodstream or other parts of the body. Its polymer technology may be able to address many health conditions in need of viable treatment options. Its VELTASSA (patiromer) for oral suspension is a commercialized medicine resulting from its polymer technology platform. VELTASSA is a potassium binder approved for the treatment of hyperkalemia. Available in powder form, VELTASSA is mixed with water and taken daily. VELTASSA's spherical beads bind to potassium in exchange for calcium, primarily in the colon.

Receive RLYP News and Ratings via Email

Sign-up to receive the latest news and ratings for RLYP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-1,601.53%
Return on Equity-227.26%
Return on Assets-115.06%


Outstanding Shares44,840,000
Market Cap$0.00

Relypsa (NASDAQ:RLYP) Frequently Asked Questions

What is Relypsa's stock symbol?

Relypsa trades on the NASDAQ under the ticker symbol "RLYP."

How were Relypsa's earnings last quarter?

Relypsa Inc (NASDAQ:RLYP) posted its earnings results on Wednesday, May, 4th. The biotechnology company reported ($1.26) earnings per share for the quarter, beating analysts' consensus estimates of ($1.46) by $0.20. The biotechnology company earned $12.40 million during the quarter, compared to analyst estimates of $6.88 million. Relypsa had a negative net margin of 1,601.53% and a negative return on equity of 227.26%. During the same period last year, the firm posted ($0.78) earnings per share. View Relypsa's Earnings History.

What is the consensus analysts' recommendation for Relypsa?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Relypsa in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Has Relypsa been receiving favorable news coverage?

News stories about RLYP stock have been trending somewhat positive this week, Accern reports. Accern scores the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Relypsa earned a media sentiment score of 0.24 on Accern's scale. They also gave media headlines about the biotechnology company an impact score of 44.90 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of Relypsa?

Shares of RLYP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Relypsa's stock price today?

One share of RLYP stock can currently be purchased for approximately $31.99.

How can I contact Relypsa?

Relypsa's mailing address is 100 Cardinal Way, REDWOOD CITY, CA 94063-4755, United States. The biotechnology company can be reached via phone at +1-650-4219500.

MarketBeat Community Rating for Relypsa (NASDAQ RLYP)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  401 (Vote Outperform)
Underperform Votes:  198 (Vote Underperform)
Total Votes:  599
MarketBeat's community ratings are surveys of what our community members think about Relypsa and other stocks. Vote "Outperform" if you believe RLYP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RLYP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2018 by Staff

Featured Article: Closed-End Mutual Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.